AI-generated summary
The authors describe a planned single-centre randomised controlled trial in Nigeria comparing low-level laser therapy with muscle energy technique, and a control group, in 60 diabetic patients with frozen shoulder. This is a study protocol, so no results are reported. The primary outcome is shoulder function, with pain, range of motion, IL-6, depression, anxiety and quality of life as secondary outcomes.
- Participants
- 60
- Who or what was studied
- Diabetic patients with frozen shoulder at Ahmadu Bello University Teaching Hospital, Zaria, Nigeria (planned sample of 60)
- Limits stated in the abstract
- This is a study protocol with no outcome results, and the abstract does not state the laser wavelength.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Diabetes mellitus is one of the fastest-growing health challenges of the twenty-first century with multifactorial impact including high rates of morbidity and mortality as well as increased healthcare costs. It is associated with musculoskeletal complications, with frozen shoulder being commonly reported. While low-level laser therapy (LLLT) and muscle energy technique (MET) are commonly used to manage this condition, there remains a lack of agreement on the most effective approach, with limited research available on their comparative efficacy.
Objectives
To evaluate the comparative effectiveness of LLLT versus MET among diabetic patients with frozen shoulder.
Methods
This is a single-centre, prospective, single-blind, randomised controlled trial with three parallel groups to be conducted at Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria. Sixty diabetic patients with frozen shoulder will be randomly assigned into LLLT group, MET group, or control group in a 1:1:1 ratio. All the groups will receive treatment three times weekly for 8 weeks. The primary outcome will be shoulder function and the secondary outcomes will include pain intensity, shoulder ROM, interleukin-6 (IL-6), depression, anxiety, and quality of life (QoL). All outcomes will be assessed at baseline, at post 8-week intervention, and at 3 months follow-up.
Discussion
This will be the first randomised controlled trial to evaluate the comparative effectiveness of LLLT versus MET on both clinical and psychological parameters among diabetic patients with frozen shoulder. The findings of the study may provide evidence on the efficacy of these interventions and most likely, the optimal treatment approach for frozen shoulder related to diabetes, which may guide clinical practice.
Trial Registration
Pan African Clinical Trials Registry (PACTR202208562111554). Registered on August 10, 2022.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Trial registration, Primary outcome, Control group, Depression, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.